- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06427096
Effect of Healthy Family Program on Population Blood Pressure
March 2, 2026 updated by: Heart Health Research Center
Effect of Healthy Family Program on Population Blood Pressure: A 1:1 Parallel Design, Multi-Center Cluster Randomized Trial
This is a 1:1 parallel design, multi-center, cluster-randomized control trial.
A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group.
At least 100 participants from 30-50 families in each village will be included in this study.
The intervention group will engage in a variety of strategies, including educating a healthy lifestyle, adopting a low-sodium diet, managing weight, participating in physical exercise, monitoring blood pressure, and undergoing antihypertensive treatment.
These efforts will be led by family health instructors from the community.
The control group will receive usual care.
The primary endpoint of this study is the change of systolic blood pressure from baseline to 6 months, reported as the difference between intervention and control group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This cluster-randomized control trial aims to randomly allocate 80 villages in Ruyan County to either receive a multifaceted intervention led by family health instructors or continue with usual care.
Each village will recruit around 100 individuals aged 40-80 years, with or without hypertension.
In intervention villages, a blood pressure management team, headed by family health instructors and family leaders, will implement various strategies including promoting a low-sodium diet, weight management, physical exercise, blood pressure monitoring, and administering antihypertensive treatment.
The intervention will span 6 months, followed by another 6-month follow-up period.
The primary hypothesis posits that the mean systolic blood pressure change from baseline to 6 months will be higher in the intervention group compared to the control group.
The objective of this "Health Family Program" is to evaluate the efficacy of a non-healthcare provider-led multifaceted intervention in enhancing healthy lifestyles and managing blood pressure among rural residents, regardless of their hypertension status, in China.
Study Type
Interventional
Enrollment (Actual)
8001
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Henan
-
Luoyang, Henan, China
- Ruyang County People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Village screening:
Villages were eligible for inclusion if they had ≥200 permanent households, with ≥60 households comprising ≥2 family members.
- Inclusion and Exclusion Criteria for the Family
Inclusion Criteria:
- At least 2 participants between the age of 40-80 years meet the inclusion and exclusion criteria of family members and willing to participate in this study;
- At least one family member can use the smartphone to upload BP values.
Exclusion Criteria:
- Any family member participated in the other hypertension-related programs;
- Inappropriate for the study decided by the healthy family instructor.
3.Inclusion and Exclusion Criteria for the Family Member
Inclusion Criteria:
- 40-80 years old, regardless of BP level and antihypertensive treatment;
- No travel plan for more than 1 month during the study period;
- Written or fingerprinted informed consent form.
Exclusion Criteria:
- Significant cognitive dysfunction;
- With advanced tumor, dialysis, or other serious diseases;
- Lying in bed for a long time or unable to take care of themselves;
- Diagnosed of secondary hypertension;
- Having birth plans in the next six months, pregnant or lactating women;
- Other ineligible circumstances judged by the investigators.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
Residents in this group will receive usual lifestyle and health care management.
|
|
|
Experimental: Multifaceted intervention
Residents in this group will receive multifaceted intervention including education for a healthy lifestyle, free provision of sodium substitute, weight management, physical exercise, BP monitoring, and appropriate antihypertensive treatment for individuals with hypertension.
|
The multifaceted interventions is comprised of the following components:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The changes of systolic blood pressure from baseline to 6 months
Time Frame: 6 months
|
The systolic blood pressure changes from baseline to 6 months for all villagers, reported as the difference between intervention and control group.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The changes of diastolic blood pressure from baseline to 6 months
Time Frame: 6 months
|
The diastolic blood pressure changes from baseline to 6 months, reported as the difference between intervention and control group.
|
6 months
|
|
The changes of systolic blood pressure from baseline to 12 months
Time Frame: 12 months
|
The systolic blood pressure changes from baseline to 12 months, reported as the difference between intervention and control group.
|
12 months
|
|
The proportion of participants with antihypertensive therapy at 6 months
Time Frame: 6 months
|
The proportion of participants with antihypertensive therapy at 6 months
|
6 months
|
|
The proportion of participants with SBP<130 or DBP<80 mmHg at 6 months
Time Frame: 6 months
|
The proportion of participants with SBP<130 or DBP<80 mmHg at 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jun Cai, MD, Beijing Anzhen Hospital
- Principal Investigator: Xin Du, MD, Beijing Anzhen Hospital
- Principal Investigator: Craig S Anderson, MD, Institute of Science and Technology for Brain-Inspired Intelligence
- Principal Investigator: Chao Jiang, MD, Beijing Anzhen Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2024
Primary Completion (Actual)
February 12, 2025
Study Completion (Actual)
July 28, 2025
Study Registration Dates
First Submitted
May 18, 2024
First Submitted That Met QC Criteria
May 18, 2024
First Posted (Actual)
May 23, 2024
Study Record Updates
Last Update Posted (Actual)
March 4, 2026
Last Update Submitted That Met QC Criteria
March 2, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- HFP2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareRecruitingBlood Pressure Measurement | Blood PressureFinland
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland
Clinical Trials on Multifaceted intervention
-
University of TorontoCanadian Institutes of Health Research (CIHR)Completed
-
Third Affiliated Hospital, Sun Yat-Sen UniversitySir Run Run Shaw Hospital; The First People's Hospital of Hefei; The Second Affiliated... and other collaboratorsRecruiting
-
National Taiwan University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedGlobal Medical Assessment of Elderly Frail PatientsFrance
-
Aga Khan UniversityImperial College London; Wellcome TrustCompletedOccupational Diseases | Occupational Lung DiseasePakistan
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedAdverse Drug ReactionBrazil
-
McGill UniversityCompleted
-
Maastricht University Medical CenterThe Netherlands Asthma FoundationCompletedObesity | Overweight | AsthmaNetherlands
-
Pontificia Universidad Catolica de ChileAgencia Nacional de Investigacion y Desarrollo, ANIDCompleted